The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
This news article is based on a press release statement from Axsome Therapeutics (NASDAQ:AXSM). The company continues to focus on addressing critical gaps in CNS treatment and advancing patient ...
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...